Cargando…

Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified N-Acetylmannosamine (ManNAc) Analogs

This report describes novel thiol-modified N-acetylmannosamine (ManNAc) analogs that extend metabolic glycoengineering (MGE) applications of Ac(5)ManNTGc, a non-natural monosaccharide that metabolically installs the thio-glycolyl of sialic acid into human glycoconjugates. We previously found that Ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Jian, Agatemor, Christian, Saeui, Christopher T., Bhattacharya, Rahul, Jia, Xiaofeng, Yarema, Kevin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918483/ https://www.ncbi.nlm.nih.gov/pubmed/33673061 http://dx.doi.org/10.3390/cells10020377

Ejemplares similares

Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study
por: Carrillo, Nuria, et al.
Publicado: (2021)

Population Pharmacokinetic Model of N-acetylmannosamine (ManNAc) and N-acetylneuraminic acid (Neu5Ac) in Subjects with GNE Myopathy
por: Van Wart, Scott, et al.
Publicado: (2021)

Comparison of Three Glycoproteomic Methods for the Analysis of the Secretome of CHO Cells Treated with 1,3,4-O-Bu(3)ManNAc
por: Mertz, Joseph L., et al.
Publicado: (2020)

Metabolic Glycoengineering Sensitizes Drug-Resistant Pancreatic Cancer Cells to Tyrosine Kinase Inhibitors Erlotinib and Gefitinib
por: Mathew, Mohit P., et al.
Publicado: (2015)

Facile synthesis of nitrophenyl 2-acetamido-2-deoxy-α-D-mannopyranosides from ManNAc-oxazoline
por: Křenek, Karel, et al.
Publicado: (2012)

A versatile design platform for glycoengineering therapeutic antibodies
por: Ludwig, Seth D., et al.
Publicado: (2022)

Improving Schwann Cell Differentiation from Human Adipose Stem Cells with Metabolic Glycoengineering
por: Du, Jian, et al.
Publicado: (2023)

Inhibition of the key enzyme of sialic acid biosynthesis by C6-Se modified N-acetylmannosamine analogs
por: Nieto-Garcia, Olaia, et al.
Publicado: (2016)

Strategies for Glycoengineering Therapeutic Proteins
por: Dammen-Brower, Kris, et al.
Publicado: (2022)

Crystal Structure of the N-Acetylmannosamine Kinase Domain of GNE
por: Tong, Yufeng, et al.
Publicado: (2009)

Crystal structure of N-acetylmannosamine kinase from Fusobacterium nucleatum
por: Caing-Carlsson, Rhawnie, et al.
Publicado: (2017)

Structure and Function of N-Acetylmannosamine Kinases from Pathogenic Bacteria
por: Gangi Setty, Thanuja, et al.
Publicado: (2020)

The Applications of Metabolic Glycoengineering
por: Ying, Liwei, et al.
Publicado: (2022)

Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells
por: Mathew, Mohit P., et al.
Publicado: (2016)

One-step synthesis of site-specific antibody–drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates
por: Shi, Wei, et al.
Publicado: (2022)

Rationale and Design for a Phase 1 Study of N-Acetylmannosamine for Primary Glomerular Diseases
por: Huizing, Marjan, et al.
Publicado: (2019)

Engineering O-glycosylation in modified N-linked oligosaccharide (Man(12)GlcNAc(2)∼Man(16)GlcNAc(2)) Pichia pastoris strains
por: Li, Siqiang, et al.
Publicado: (2019)

Improving the Pharmacodynamics and In Vivo Activity of ENPP1‐Fc Through Protein and Glycosylation Engineering
por: Stabach, Paul R., et al.
Publicado: (2020)

Genetic glycoengineering in mammalian cells
por: Narimatsu, Yoshiki, et al.
Publicado: (2021)

Metabolic Glycoengineering with Azide‐ and Alkene‐Modified Hexosamines: Quantification of Sialic Acid Levels
por: Dold, Jeremias E. G. A., et al.
Publicado: (2020)

Cyclopropene derivatives of aminosugars for metabolic glycoengineering
por: Hassenrück, Jessica, et al.
Publicado: (2019)

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
por: Li, Wei, et al.
Publicado: (2017)

Direct quality control of glycoengineered erythropoietin variants
por: Čaval, Tomislav, et al.
Publicado: (2018)

Applying Acylated Fucose Analogues to Metabolic Glycoengineering
por: Rosenlöcher, Julia, et al.
Publicado: (2015)

Protein Glycoengineering: An Approach for Improving Protein Properties
por: Ma, Bo, et al.
Publicado: (2020)

Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors
por: Li, Shasha, et al.
Publicado: (2021)

Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells
por: Tian, Yuan, et al.
Publicado: (2015)

Engineering the yeast Yarrowia lipolytica for the production of therapeutic proteins homogeneously glycosylated with Man(8)GlcNAc(2) and Man(5)GlcNAc(2)
por: De Pourcq, Karen, et al.
Publicado: (2012)

Cell Surface and Membrane Engineering: Emerging Technologies and Applications
por: Saeui, Christopher T., et al.
Publicado: (2015)

Rapid access to phospholipid analogs using thiol-yne chemistry
por: Zhou, Cun Yu, et al.
Publicado: (2015)

Generation of triacyl lipopeptide-modified glycoproteins by metabolic glycoengineering as the neoantigen to boost anti-tumor immune response
por: Zhao, Yujia, et al.
Publicado: (2021)

Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties
por: Luo, Cheng, et al.
Publicado: (2017)

Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies
por: Tytgat, Hanne L. P., et al.
Publicado: (2019)

N-acetylmannosamine-6-phosphate 2-epimerase uses a novel substrate-assisted mechanism to catalyze amino sugar epimerization
por: Currie, Michael J., et al.
Publicado: (2021)

Improving Immunotherapy Through Glycodesign
por: Buettner, Matthew J., et al.
Publicado: (2018)

Investigations of thiol-modified phenol derivatives for the use in thiol–ene photopolymerizations
por: Reinelt, Sebastian, et al.
Publicado: (2014)

Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides
por: Altmann, Stephan, et al.
Publicado: (2021)

Thiol-ene Enabled Chemical Synthesis of Truncated S-Lipidated Teixobactin Analogs
por: Yim, Victor V., et al.
Publicado: (2020)

IgG-Fc glycoengineering in non-mammalian expression hosts
por: Loos, Andreas, et al.
Publicado: (2012)

Labeling glycans on living cells by a chemoenzymatic glycoengineering approach
por: Almaraz, Ruben T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1egraci9r8gtfal6uvta7no450